Insider buying last 90 days
No open-market insider purchases were filed for AEHR in the last 90 days.
From Form 4 filings, dated to when each was filed.
Oct 12 close
Aehr Test Systems shares moved this week on continued news of its push into AI processor testing, with a $6 million follow-on order from its lead hyperscale customer for package-level burn-in of a next-generation AI processor, expanding testing capacity ahead of an anticipated production ramp in 2027. The company also confirmed it will report first-quarter fiscal 2027 results on 2 November 2026 after market close. Alongside this, commentary has noted the stock's recent decline even as bookings and long-term momentum remain described as strong, with one report highlighting a healthy cash balance of $34 million and no significant debt.
AEHR closed at $78.18, down 7.6%, sitting between its 50-day average of $97.98 and 200-day average of $71.64, with one-month performance at -17.4% against a one-year return of 210.9%. The GekkoIndex reads 65.5, placing the stock in the Accumulation zone. Price sits 22.6% below Gekko Fair Value of $101.03.
Over the next 20 trading days, the main event is the 2 November earnings report, falling within that window; the prior release on 14 July beat estimates with a 29.1% reaction, and the company has beaten EPS estimates in 5 of the last 8 quarters, with an average absolute reaction of 19.5%. No insider, Congress or unusual options activity appears in the current windows. Seasonally, the next 20 trading days have averaged a 0.6% return over 5 years, positive in 3 of them. Five analysts covering the stock currently rate it buy, with a consensus target of $128.
Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.
Aehr Test Systems scores 3 supportive, 1 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive1 mixed1 headwind
Averages disagree
Close $78.18 sits between the 50-day ($97.98) and 200-day ($71.64) averages, or the averages disagree.
See the chart65.5, Accumulation
Reading 65.5 is in the Accumulation zone.
See the GekkoIndex22.6% below
Price is 22.6% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 21 days
Reports on Nov 2, 2026, 21 days away — inside a typical 20-trading-day hold.
See earnings+0.6% on average
From this point in the calendar, the next 20 trading days averaged +0.6% over 5 years, rising in 3 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Aehr Test Systems closed at $78.18 on Oct 12, 2026, +210.9% over the past year, inside a 52-week range of $18.70 to $147.40.
Use the left and right arrow keys to read daily values.
Put AEHR on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Aehr Test Systems builds equipment used to burn in and test integrated circuits, including logic, memory and optical devices, for semiconductor manufacturers worldwide. The company is perhaps best recognized for its FOX line of systems, which handle wafer- and die-level burn-in and functional testing for complex chips such as processors, controllers, systems-on-a-chip and photonic components.
Its product range spans several related lines. The ABTS system targets production and qualification testing of packaged parts across various logic and memory types, while the FOX-XP, FOX-NP and FOX-CP systems address wafer-level and single-wafer testing needs. Supporting hardware includes the WaferPak Contactor, a full-wafer probe card that works with wafers up to 300mm, and the DiePak Carrier, a reusable packaging format that lets manufacturers run final test and burn-in on bare die and modules. Together these offerings serve chipmakers that need to verify device reliability before devices reach the market.
Shares of Aehr Test Systems trade on the NASDAQ under the ticker AEHR.
Aehr Test Systems’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 65.5, in the Accumulation zone, up 11.5 points over five sessions.
Up 11.5 points over five sessions, from the Neutral zone.
Reading for Oct 12, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 31 | +4.8% | +9.5% | ||
| Accumulation (current zone) | 244 | +2.2% | +7.5% | ||
| Neutral | 353 | +2.3% | +11.4% | ||
| Distribution | 51 | +2.0% | +6.6% | ||
| Selling | 3 | Too few readings yet | |||
Average AEHR share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.2% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
Aehr Test Systems trades 22.6% below Gekko Fair Value of $101.03, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Aehr Test Systems shares are worth, recalculated every trading day.
$101.03
Gekko Fair Value, Oct 10, 2026
22.6% Undervalued
At the end of Aug 2026 the price was 32.2% below the estimate.
No open-market insider purchases were filed for Aehr Test Systems, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for AEHR in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in AEHR were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Aehr Test Systems has been buying back its own shares.
From company filings.
0of the funds Gekko tracks hold AEHR.
Aehr Test Systems reports on Nov 2, 2026, after the close (21 days away), and beat the EPS estimate in 5 of its last 8 reports.
Nov 2, 2026
Expected after the close, 21 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 14, 2026 | $0.05 est −$0.06 | $18.80M est $18.69M | +29.1% |
| Apr 7, 2026 | −$0.05 est −$0.07 | $10.30M est $10.85M | +21.1% |
| Jan 8, 2026 | −$0.04 est −$0.03 | $9.90M est $11.58M | +8.9% |
| Oct 6, 2025 | $0.01 est $0.01 | $10.97M est $11.12M | −15.7% |
| Jul 8, 2025 | −$0.01 est −$0.01 | $14.09M est $14.82M | −10.3% |
| Apr 8, 2025 | $0.07 est $0.01 | $18.31M est $14.83M | +21.3% |
| Jan 13, 2025 | $0.02 est $0.03 | $13.45M est $19.68M | −28.9% |
| Oct 10, 2024 | $0.07 est $0.02 | $13.12M est $12.17M | +21.1% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Aehr Test Systems is $128.00, +63.7% from the last close, from 5 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 5 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 10 | Oppenheimer | $120 | +53.5% |
| Aug 12 | William Blair | — | — |
| Jul 16 | Freedom Capital Markets | $110 | +40.7% |
| Jul 15 | Craig-Hallum | $125 | +59.9% |
| Jul 15 | Lake Street | $110 | +40.7% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Oct 10, Aehr Test Systems averaged +0.6% across the last 5 years, rising in 3 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +3.2% | 4 of 5 |
| Next 10 trading days | +8.7% | 4 of 5 |
| Next 15 trading days | +3.7% | 4 of 5 |
| Next 20 trading days | +0.6% | 3 of 5 |
| Next 30 trading days | −5.9% | 1 of 5 |
For scale, AEHR’s typical 20-trading-day move in either direction is about 18.5%.
Aehr Test Systems’s market cap is $2.55B and revenue of $50.00M over the last twelve months.
Coverage of Aehr Test Systems this week reads positive: 6 positive, 4 neutral and 2 negative headlines.
Aehr Test Systems’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| VRTVertiv | Accumulation | 10.4% below |
| BEBloom Energy | Neutral | 0.3% above |
| TERTeradyne | Neutral | 3.3% above |
| FLEXFlex | Neutral | 1.5% above |
| SANMSanmina | Neutral | 4.0% above |
| AEISAdvanced Energy Industries | Neutral | 8.2% below |
A peer links to its own page where one exists.
Aehr Test Systems’s market cap is $2.55B at the Oct 12, 2026 close of $78.18, with 32.66M shares outstanding.
The consensus analyst 12-month price target for Aehr Test Systems is $128.00, +63.7% from the last close. Of the 5 firms that rated the stock in the last 90 days, 5 rate it a buy, 0 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Aehr Test Systems is undervalued: the Oct 12, 2026 close of $78.18 is 22.6% below Gekko Fair Value of $101.03. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Aehr Test Systems is expected to report on Nov 2, 2026, after the market closes (21 days away). Analysts expect earnings of $0.11 per share on revenue of $26.60M. Aehr Test Systems beat the earnings estimate in 5 of its last 8 reports, moving 19.5% on average across the report.
Aehr Test Systems’s 52-week high is $147.40 and its 52-week low is $18.70; it closed at $78.18 on Oct 12, 2026, +210.9% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (gekkoindex, fair value and seasonality), 1 as mixed (trend) and 1 as a headwind (earnings risk). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,408 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.